GlassScriptPhysician profile
Andrea Tuttle
NPI 1215382619
$2,606.89
in general payments reported to CMS, 2019-2025
21 companies · $384 in 2025
The $384 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $390 · 2021: $300 · 2022: $398 · 2023: $430 · 2024: $446 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $513.38 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $359.66 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $254.89 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $240.56 | 2020-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $210.11 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $154.07 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $149.80 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $109.56 | 2022-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Phadia US INC. | $103.02 | 2019 | |
| Pfizer INC. | $92.93 | 2020-2024 | |
| Tempus Ai, INC | $91.94 | 2024 | |
| Neos Therapeutics, LP | $75.22 | 2022-2024 | Cotempla Xr-Odt |
| Glaxosmithkline, LLC. | $74.77 | 2023-2024 | Bexsero |
| Sanofi-Aventis U.S. LLC | $46.09 | 2025 | |
| Sobi, INC | $28.50 | 2020-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $19.33 | 2025 | Doc Band |
| Nestle Healthcare Nutrition INC. | $18.91 | 2023 | |
| Verrica Pharmaceuticals INC. | $18.01 | 2023 | Ycanth |
| Organon LLC | $17.51 | 2022 | |
| Adlon Therapeutics L.P. | $14.50 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.13 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Tuttle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.